Atlas Trials

Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients

Clinical trial NCT07118384 · RECRUITING

Trial details

NCT number
NCT07118384
Sponsor
Cairo University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Acinetobacter Baumannii Infection
Start date
2025-05-01
Primary completion
2026-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.